ISO Certification For Biopharma's Nottingham Production Facility

Nottingham, UK - It's a great start to the New Year for Novozymes Biopharma. As part of its ongoing environmental legislative compliance, Biopharma's Nottingham based production facility has achieved ISO14001 certification – the globally recognized standard for Environmental Management for its Environmental Management System (EMS) from the British Standards Institute (BSI).

Time and effort well rewarded
Roger Freestone, Director of Engineering commented "This certification was achieved after around 18 months work which was carried out under the direction of the Nottingham site's Environmental, Health and Safety Steering Group to support compliance of the site's IPPC (Integrated Pollution Prevention and Control) Permit. The IPPC Permit is regulated by the UK Environment Agency.

Roger adds, "Our EMS is integrated into existing QA systems which are in place to support our cGMP compliance for the production of Recombumin®, recombinant human albumin. Both BSI and the UK Environment Agency were complimentary about the Training, the Maintenance and Calibration Management databases that are in use in Nottingham."

Cross site continuity and future ambitions
This certification brings the Nottingham facility in line with the majority of the other Novozymes production sites.

Objectives and targets have been identified as part of the EMS and to support these, an Environmental Forum has been set up at the production facility to address these targets.

Steve Garland, Novozymes Biopharma UK Ltd's Operations Director explains the scope of the achievement, "This is the culmination of a long period of sustained focus by all employees working at the manufacturing site. Proving that the Environmental Management System meets the exacting standards set by ISO is a significant accomplishment and everyone should be very proud of the achievement."

About Novozymes:
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources.

With over 700 products used in 130 countries, Novozymes' bioinnovations improve industrial performance and safeguard the world's resources by offering superior and sustainable solutions for tomorrow's ever-changing marketplace.

Novozymes' natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature's potential is evidenced by over 4,500 patents, showing what is possible when nature and technology join forces.

Our 4,500+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.

SOURCE: Novozymes Biopharma US Inc.